Document:

Registration Rights Agreement dated October 31, 2007

 Exhibit 4.3 
 EXECUTION VERSION 
  

 Registration Rights Agreement 
 Dated as of October 31, 2007

 among 
 Lincare
Holdings Inc. 
 and 
 Merrill Lynch, Pierce, Fenner & Smith 
 Incorporated 
 and 
 Deutsche Bank Securities Inc. 
  

 REGISTRATION RIGHTS AGREEMENT 
 This Registration Rights Agreement (the “Agreement”) is made and entered into this
31st day of October, 2007, among Lincare Holdings Inc., a Delaware corporation (the “Company”), Merrill Lynch, Pierce, Fenner & Smith
Incorporated (“Merrill Lynch”), Deutsche Bank Securities Inc. (“Deutsche Bank”) and each of the initial purchasers named in Schedule A to the Purchase Agreement (collectively, the “Initial Purchasers”), for whom Merrill
Lynch and Deutsche Bank are acting as representatives (in such capacity, the “Representatives”). 
 This Agreement is made
pursuant to the Purchase Agreement (the “Purchase Agreement”), dated October 25, 2007, among the Company and the Initial Purchasers, which provides for the sale by the Company to the Initial Purchasers, acting severally and not
jointly, of (i) $250,000,000 aggregate principal amount ($275,000,000 aggregate principal amount if the Initial Purchasers exercise their over-allotment option in full) of the Company’s Convertible Senior Debentures due 2037 – Series
A (the “Series A Securities”) and (ii) $250,000,000 aggregate principal amount ($275,000,000 aggregate principal amount if the Initial Purchasers exercise their over-allotment option in full) of the Company’s Convertible Senior
Debentures due 2037 – Series B (the “Series B Securities” and together with the Series A Securities, the “Debentures” and together with the shares of Common Stock of the Company into which the Debentures are convertible, the
“Securities”). In order to induce the Initial Purchasers to enter into the Purchase Agreement, the Company has agreed to provide to the Initial Purchasers and their direct and indirect transferees the registration rights set forth in this
Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement. 
 In consideration of the foregoing,
the parties hereto agree as follows: 
 1. Definitions. 
 As used in this Agreement, the following capitalized defined terms shall have the following meanings: 
 “1933 Act” shall mean the Securities Act of 1933, as amended from time to time. 
 “1934 Act” shall mean the Securities Exchange Act of l934, as amended from time to time. 
 “1939 Act” shall mean the Trust Indenture Act of 1939, as amended from time to time. 
 “Additional Interest” shall have the meaning set forth in Section 2.4 herein. 
 “Agreement” shall have the meaning set forth in the preamble. 
 “Closing Date”
shall mean the Closing Time as defined in the Purchase Agreement. 
  

 1 

 “Common Stock” shall mean any shares of common stock, par value $0.01
per share, of the Company and any other shares of common stock as may constitute “Common Stock” for purposes of the Indentures. 
 “Company” shall have the meaning set forth in the preamble and shall also include the Company’s successors. 
 “Debentures” shall have the meaning set forth in the preamble. 
 “Depositary” shall mean The Depository Trust Company, or any other depositary appointed by the Company, provided,
however, that such depositary must have an address in the Borough of Manhattan, in the City of New York. 
 “Deutsche Bank” shall have the meaning set forth in the preamble. 
 “Effectiveness
Period” shall have the meaning set forth in Section 2.1(b) herein. 
 “FINRA” shall mean the
Financial Industry Regulatory Authority, Inc. (successor to the National Association of Securities Dealers, Inc.). 
 “Holder” shall mean any Initial Purchaser, for so long as it owns any Registrable Securities, and its successors, assigns and direct and indirect transferees who become owners, beneficial or otherwise, of Registrable
Securities under the Indentures. 
 “Holders’ Counsel” shall mean a single counsel to the Holders in
connection with the Shelf Registration Statement. 
 “Indentures” shall mean, collectively, the Indenture
relating to the Series A Securities, dated as of the date hereof, between the Company and U.S. Bank National Association, as Trustee, as the same may be amended, supplemented, waived or otherwise modified from time to time in accordance with the
terms thereof and the Indenture relating to the Series B Securities, dated as of the date hereof, between the Company and U.S. Bank National Association, as Trustee, as the same may be amended, supplemented, waived or otherwise modified from time to
time in accordance with the terms thereof. 
 “Initial Purchaser” “or “Initial
Purchasers” shall have the meaning set forth in the preamble. 
 “Issuer Free Writing Prospectus”
shall have the meaning set forth in Section 2.1(f) herein. 
 “Majority Holders” shall mean the Holders
of a majority of the aggregate principal amount of outstanding Registrable Securities; provided that, for purposes of this definition, (1) a Holder of shares of Common Stock that constitutes Registrable Securities which were issued upon
conversion of the Notes shall be deemed to hold an aggregate principal amount at maturity of Registrable Securities (in addition to the principal amount at maturity of any Registrable Securities held by such Holder) equal to the principal 

  

 2 

 
amount at maturity of Registrable Securities which were converted into such shares of Common Stock and (2) such Registrable Securities which were
converted into such shares of Common Stock shall be deemed to be outstanding; provided further, that whenever the consent or approval of Holders of a specified percentage of Registrable Securities is required hereunder, Registrable Securities
held by the Company or any Affiliate (as defined in the Indentures) of the Company shall be disregarded in determining whether such consent or approval was given by the Holders of such required percentage amount. 
 “Merrill Lynch” shall have the meaning set forth in the preamble. 
 “Offering Memorandum” shall mean the offering memorandum of the Company, dated October 25, 2007, related to the
offering and sale of the Securities. 
 “Person” shall mean an individual, partnership (general or limited),
corporation, limited liability company, trust or unincorporated organization, or a government or agency or political subdivision thereof. 
 “Prospectus” shall mean the prospectus included in a Shelf Registration Statement, including any preliminary prospectus, and any such prospectus as amended or supplemented by any prospectus
supplement, including any such prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by a Shelf Registration Statement, and by all other amendments and supplements to a prospectus,
including post-effective amendments, and in each case including all materials incorporated by reference therein. 
 “Purchase Agreement” shall have the meaning set forth in the preamble. 
 “Questionnaire” shall have the meaning set forth in Section 2.1(d) herein. 
 “Registrable Securities” shall mean all or any of the Debentures issued from time to time under the Indentures in registered form and the shares of Common Stock issued or issuable upon conversion of such; provided,
however, that any such Securities shall cease to be Registrable Securities at the earlier of when (i) a Shelf Registration Statement with respect to such Securities shall have been declared effective or otherwise become effective under
the 1933 Act and such Securities shall have been disposed of pursuant to such Shelf Registration Statement, (ii) such Securities have been sold to the public pursuant to Rule 144 or may be sold or transferred pursuant to Rule l44(k) (or any
similar provision then in force, but not Rule 144A) under the 1933 Act by Holders who are not “affiliates” of the Company and (iii) such Securities shall have ceased to be outstanding. 
 “Registration Default” shall have the meaning set forth in Section 2.4 herein. 
 “Registration Expenses” shall mean any and all expenses incident to performance of or compliance by the Company with this
Agreement, whether or not a Shelf Registration Statement becomes effective, including without limitation: (i) all SEC, stock exchange or FINRA registration and filing fees, including, if applicable, the reasonable and documented fees and
expenses of any “qualified independent 

  

 3 

 
underwriter” (and its counsel) that is required to be retained by any holder of Registrable Securities in accordance with the rules and regulations of
the FINRA, (ii) all fees and expenses incurred by the Company in connection with compliance with state securities or blue sky laws and compliance with the rules of the FINRA (including reasonable and documented fees and disbursements of counsel
for any underwriters or Holders in connection with blue sky qualification of any of the Registrable Securities and any filings with the FINRA), (iii) all expenses of the Company in preparing or assisting in preparing, word processing, printing
and distributing any Shelf Registration Statement, any Prospectus, any amendments or supplements thereto, any securities sales agreements and other documents relating to the performance of and compliance with this Agreement, (iv) all fees and
expenses incurred by the Company in connection with the listing, if any, of any of the Registrable Securities on any securities exchange or exchanges, (v) all rating agency fees incurred by the Company, if any, (vi) the fees and
disbursements of counsel for the Company and of the independent public accountants of the Company, including the expenses of any special audits or “comfort” letters required by or incident to such performance and compliance, (vii) the
fees and expenses of the Trustee, and any escrow agent or custodian, (viii) the reasonable and documented fees and expenses of the Holders’ Counsel and (ix) any fees and expenses of any special experts retained by the Company in
connection with any Shelf Registration Statement, but excluding any underwriting discounts and commissions and transfer taxes, if any, relating to the sale or disposition of Registrable Securities by a Holder and the fees and expenses of any counsel
to the Holders, except as provided for in clause (viii) above. 
 “Registration Statement Termination
Date” shall have the meaning set forth in Section 2.1(b) herein. 
 “Representatives” shall
have the meaning set forth in the preamble. 
 “SEC” shall mean the Securities and Exchange Commission or any
successor agency or government body performing the functions currently performed by the United States Securities and Exchange Commission. 
 “Securities” shall have the meaning set forth in the preamble. 
 “Series A Securities” shall have the meaning set forth in the preamble. 
 “Series B
Securities” shall have the meaning set forth in the preamble. 
 “Shelf Registration” shall mean a
registration effected pursuant to Section 2.1 hereof. 
 “Shelf Registration Statement” shall mean a
“shelf” registration statement of the Company pursuant to the provisions of Section 2.1 of this Agreement which covers all of the Registrable Securities on an appropriate form under Rule 415 under the 1933 Act, or any similar rule
that may be adopted by the SEC, and all amendments and supplements to such registration statement, including post-effective amendments, in each case including the Prospectus contained therein, all exhibits thereto and all materials incorporated by
reference therein. 
  

 4 

 “Suspension Period” shall have the meaning set forth in Section 2.5
herein. 
 “Trustee” shall mean the trustee with respect to the Securities under the Indentures. 

“Underwriter” shall have the meaning set forth in Section 4(a) herein. 
 2. Registration Under the 1933 Act. 
 2.1 Shelf Registration. 
 (a) The Company shall, at its cost, no later than 90 days after the Closing Date, file with SEC,
and thereafter shall use its reasonable best efforts to cause to become effective as promptly as is practicable but in no event later than 210 days after the Closing Date, a Shelf Registration Statement relating to the offer and sale of the
Registrable Securities by the Holders that have provided the information pursuant to Section 2.1(d). 
 (b) The Company shall, at its
cost, use its reasonable best efforts, subject to Section 2.5, to keep the Shelf Registration Statement continuously effective in order to permit the Prospectus forming part thereof to be usable by Holders for the period (the
“Effectiveness Period”) beginning upon the effective date of the Shelf Registration Statement until the earliest to occur of (1) the sale pursuant to the Shelf Registration Statement of all of the Securities, (2) the date when
the Holders, other than Holders that are “affiliates” (as defined in Rule 405 under the 1933 Act) of the Company, are able to sell all such Securities immediately without restriction pursuant to the provisions of Rule 144 under the 1933
Act or any successor Rule thereto or otherwise and (3) the date that is two years from the Closing Date (the earliest such occurrence the “Registration Statement Termination Date”). 
 (c) Notwithstanding any other provisions hereof, the Company shall use its reasonable best efforts to provide that (i) any Shelf Registration
Statement and any amendment thereto and any Prospectus forming part thereof and any supplement thereto complies in all material respects with the 1933 Act and the rules and regulations thereunder, (ii) any Shelf Registration Statement and any
amendment thereto does not, when it becomes effective, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading and (iii) any
Prospectus forming part of any Shelf Registration Statement, and any supplement to such Prospectus (as amended or supplemented from time to time), does not include an untrue statement of a material fact or omit to state a material fact necessary in
order to make the statements therein, in light of the circumstances under which they were made, not misleading. 
 (d) Notwithstanding any
other provision hereof, no Holder of Registrable Securities may include any of its Registrable Securities in the Shelf Registration Statement pursuant to this Agreement unless the Holder furnishes to the Company a fully completed notice and
questionnaire in the form attached as Annex A to the Offering Memorandum (the “Questionnaire”) and such other information in writing as the Company may reasonably request in writing for use in connection with the Shelf Registration
Statement or Prospectus included therein and in any application to be filed with or under state securities laws. At least 30 days prior to the filing of the Shelf Registration Statement, the Company will provide 

  

 5 

 
notice by press release to the Holders of its intention to file the Shelf Registration Statement. In order to be named as a selling securityholder in the
Prospectus at the time of effectiveness of the Shelf Registration Statement, each Holder must, before the filing of the Shelf Registration Statement and no later than on or before the 20th day after the issuance by the Company of a press release
indicating the Company’s intention to file, furnish the completed Questionnaire and such other information that the Company may reasonably request in writing, if any, to the Company in writing and the Company shall include the information from
the completed Questionnaire and such other information, if any, in the Shelf Registration Statement and the Prospectus in a manner so that upon effectiveness of the Shelf Registration Statement the Holder will be permitted to deliver the Prospectus
to purchasers of the Holder’s Registrable Securities. From and after the date that the Shelf Registration Statement is first declared effective by the SEC or otherwise becomes effective, upon receipt of a completed Questionnaire and such other
information that the Company may reasonably request in writing, if any, the Company will use its reasonable best efforts to file within 20 business days any amendments or supplements to the Shelf Registration Statement necessary for such Holder to
be named as a selling securityholder in the Prospectus contained therein to permit such Holder to deliver the Prospectus to purchasers of the Holder’s Securities (subject to the Company’s right to suspend the Shelf Registration Statement
as described in Section 2.5 below); provided, however, that the Company shall not be required to file more than one such amendment or supplement to the Shelf Registration Statement in any calendar quarter for all such Holders.
Holders that do not deliver a completed written Questionnaire and such other information, as provided for in this Section 2.1(d), will not be named as selling securityholders in the Prospectus. Each Holder named as a selling securityholder in
the Prospectus agrees to promptly furnish to the Company all information required to be disclosed in order to make information previously furnished to the Company by the Holder not materially misleading and any other information regarding such
Holder and the distribution of such Holder’s Registrable Securities as the Company may from time to time reasonably request in writing. 
 (e) During the Effectiveness Period, each Holder agrees not to sell any Registrable Securities pursuant to the Shelf Registration Statement without delivering, or causing to be delivered, a Prospectus to the purchaser thereof. Each Holder
agrees, following the Registration Statement Termination Date, to provide information to the Company, within 10 days of the receipt by such Holder of a written request from the Company, regarding the amount of Registrable Securities sold pursuant to
the Shelf Registration Statement and, in the absence of a response, the Company may assume that all of such Holder’s Registrable Securities have been sold; provided that the Company shall use reasonable best efforts to confirm that all
of such Holder’s Registrable Securities have been so sold prior to making such assumption. 
 (f) The Company represents and agrees
that, unless it obtains the prior consent of Holders of a majority in principal amount of the Registrable Securities that are registered under the Shelf Registration Statement at such time or the approval of Holders’ Counsel or the consent of
the managing underwriter in connection with any underwritten offering of Registrable Securities, and each Holder represents and agrees that, unless it obtains the prior consent of the Company and any such underwriter, it will not make any offer
relating to the Securities (which, for the avoidance of doubt, will not include any shares of Common Stock which are not Securities within the meaning of this Agreement) that would constitute an “issuer free writing prospectus,” as defined
in Rule 433 under the 1933 Act (an “Issuer Free Writing 

  

 6 

 
Prospectus”), or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405 under the 1933 Act, required to be filed
with the SEC. The Company represents that any Issuer Free Writing Prospectus will not include any information that conflicts with the information contained in the Shelf Registration Statement or Prospectus and that any Issuer Free Writing
Prospectus, when taken together with the information in the Shelf Registration Statement and the Prospectus, will not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading. 
 The Company will not permit any securities other than
Registrable Securities to be included in the Shelf Registration Statement. The Company agrees to supplement or amend the Shelf Registration Statement if required by the rules, regulations or instructions applicable to the registration form used by
the Company if required by the 1933 Act, or to the extent the Company does not reasonably object, as reasonably requested in writing by any Holder with respect to information relating to such Holder, and to furnish to the Holders of Registrable
Securities that are covered under such Shelf Registration Statement copies of any such supplement or amendment promptly after its being used or filed with the SEC in such amounts as they may reasonably request. 
 2.2 Expenses. The Company shall pay all Registration Expenses in connection with the registration pursuant to Section 2.1. Each Holder shall
pay all underwriting discounts and commissions and transfer taxes, if any, relating to the sale or disposition of such Holder’s Registrable Securities pursuant to the Shelf Registration Statement. 
 2.3 Effectiveness. (a) The Company will be deemed not to have used its reasonable best efforts to cause the Shelf Registration Statement to
become, or to remain, effective during the requisite period (subject to Section 2.5) if the Company voluntarily takes any action that would, or voluntarily omits to take any action which omission would, result in any such Shelf Registration
Statement not being declared effective or in the Holders of Registrable Securities covered thereby not being able to offer and sell such Registrable Securities during that period as and to the extent contemplated hereby, unless such action or
omission is required by applicable law. 
 (b) A Shelf Registration Statement will not be deemed to have become effective unless it has been
declared effective by the SEC or has become automatically effective under the 1933 Act; provided, however, that if, after it has been declared or become effective, the offering of Registrable Securities pursuant to a Shelf Registration
Statement is interfered with by any stop order, injunction or other order or requirement of the SEC or any other governmental agency or court, such Shelf Registration Statement will be deemed not to have become effective during the period of such
interference, until the offering of Registrable Securities pursuant to such Shelf Registration Statement may legally resume. 
 2.4 Interest. In the event that (a) a Shelf Registration Statement is not filed with
the SEC on or before the 90th calendar day following the Closing Date, (b) a Shelf Registration Statement does not become effective or otherwise becomes effective on or prior to the 210th calendar day following the Closing Date, (c) after effectiveness, subject to Section 2.5, the Shelf Registration Statement ceases to be effective or fails to be usable by
the Holders 

  

 7 

 
without being succeeded within seven business days by a post-effective amendment or a report filed with the SEC pursuant to the 1934 Act that immediately
cures the failure to be effective or usable, or (d) the Prospectus is unusable by the Holders for any reason, and the Suspension Period (as defined in Section 2.5 hereof) exceeds the number of days set forth in Section 2.5 (each such
event being a “Registration Default”), additional interest (“Additional Interest”) will accrue at a rate per annum of one-quarter of one percent (0.25%) of the principal amount of the Debentures for the first 90 day
period from the day following the Registration Default, and thereafter at a rate per annum of one-half of one percent (0.50%) of the principal amount of the Debentures; provided that in no event shall Additional Interest accrue at a rate per
annum exceeding one half of one percent (0.50%) of the issue price of the Debentures; provided further that no Additional Interest shall accrue after the Registration Statement Termination Date. Holders that do not deliver a completed written
Questionnaire will not be entitled to receive Additional Interest. Upon the cure of all Registration Defaults then continuing, the accrual of Additional Interest will automatically cease and the interest rate borne by the Debentures will revert to
the original interest rate at such time. Additional Interest shall be computed based on the actual number of days elapsed in each 90-day period in which a Registration Default exists. Holders who have converted Debentures into Common Stock will not
be entitled to receive any Additional Interest with respect to such Common Stock or the issue price of the Debentures converted. 
 The
Company shall notify the Trustee within five business days after each and every date on which an event occurs in respect of which Additional Interest is required to be paid. Additional Interest shall be paid by depositing with the Trustee, in trust,
for the benefit of the Holders of Registrable Securities, on or before the applicable semiannual interest payment date, in immediately available funds in sums sufficient to pay the Additional Interest then due. The Additional Interest due shall be
payable in arrears on each regular interest payment date to the record Holder of Registrable Securities entitled to receive the interest payment to be paid on such date as set forth in the Indenture. Each obligation to pay Additional Interest shall
be deemed to accrue from and including the day following the Registration Default to but excluding the day on which the Registration Default is cured. 
 A Registration Default under clause (a) above shall be cured on the date that the Registration Statement is filed with the SEC. A Registration Default under clause (b) above shall be cured on the date that
the Shelf Registration Statement is declared effective by the SEC or deemed to become automatically effective under the 1933 Act. A Registration Default under clauses (c) or (d) above shall be cured on the date an amended Shelf
Registration Statement is declared effective by the SEC or deemed to become automatically effective under the 1933 Act, or the Company otherwise declares the Shelf Registration Statement and the Prospectus useable, as applicable. The Company will
have no liabilities for monetary damages other than the Additional Interest with respect to any Registration Default. 
 2.5
Suspension. Notwithstanding any other provision hereof, the Company may suspend the use of any Prospectus, without incurring or accruing any obligation to pay Additional Interest pursuant to Section 2.4 hereof or being deemed in
violation of any other provision hereof, for a period or periods (each, a “Suspension Period”) not to exceed an aggregate 45 calendar days in any three-month period, or an aggregate of 120 calendar days in any twelve-month period, if
management of the Company shall have determined in good faith 

  

 8 

 
that because of valid business reasons (not including avoidance of the Company’s obligations hereunder), including without limitation proposed or
pending corporate developments and similar events or because of filings with the SEC, it is in the best interests of the Company to suspend such use, and prior to suspending such use the Company provides the Holders with written notice of such
suspension, which notice need not specify the nature of the event giving rise to such suspension. Each Holder shall keep confidential any communications received by it from the Company regarding the suspension of the use of the Prospectus, except as
required by applicable law. 
 3. Registration Procedures. 
 In connection with the obligations of the Company with respect to the Shelf Registration, the Company shall, subject to the rights of the Company to
invoke and maintain a Suspension Period in accordance with Section 2.5 without being in violation of any of the provisions hereunder: 
 (a) prepare and file with the SEC a Shelf Registration Statement, within the relevant time period specified in Section 2, on the appropriate form under the 1933 Act, which form (i) shall be selected by the Company, (ii) shall
be available for the sale of the Registrable Securities by the selling Holders thereof, (iii) shall comply as to form in all material respects with the requirements of the applicable form and include or incorporate by reference all financial
statements required by the SEC to be filed therewith or incorporated by reference therein, and (iv) shall comply in all respects with the applicable requirements of Regulation S-T under the 1933 Act, if any, and use reasonable best efforts to
cause such Shelf Registration Statement to become effective and remain effective in accordance with Section 2 hereof; 
 (b) prepare
and file with the SEC such amendments and post-effective amendments to the Shelf Registration Statement as may be necessary under applicable law to keep the Shelf Registration Statement effective for the Effectiveness Period, subject to
Section 2.5; and cause each Prospectus to be supplemented by any required prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 (or any similar provision then in force) under the 1933 Act and comply during the
Effectiveness Period with the provisions of the 1933 Act, the 1934 Act and the rules and regulations thereunder required to enable the disposition of all Registrable Securities covered by the Shelf Registration Statement in accordance with the
intended method or methods of distribution by the selling Holders thereof; 
 (c)(i) notify each Holder of Registrable Securities of the
filing of a Shelf Registration Statement with respect to the Registrable Securities; (ii) furnish to each Holder of Registrable Securities that has provided the information required by Section 2.1(d) and to each underwriter of an
underwritten offering of Registrable Securities, if any, without charge, electronic copies of each Prospectus, including each preliminary Prospectus, and any amendment or supplement thereto and such other documents as such Holder or underwriter may
reasonably request, including financial statements and schedules and, if the Holder so requests, all exhibits in order to facilitate the unrestricted sale or other disposition of the Registrable Securities; and (iii) subject to Section 2.5
hereof and to any notice by the Company in accordance with Section 3(e) hereof of the existence of any fact of the kind described in Sections 3(e)(ii), (iii), (iv), (v) and (vi) hereof, hereby consent to the use of the Prospectus or
any amendment or supplement 

  

 9 

 
thereto by each of the selling Holders of Registrable Securities that has provided the information required by Section 2.1(d) in connection with the
offering and sale of the Registrable Securities; 
 (d) use reasonable best efforts to register or qualify the Registrable Securities for
exemptions under all applicable state securities or “blue sky” laws of such jurisdictions in the United States as any Holder of Registrable Securities covered by a Shelf Registration Statement and each underwriter of an underwritten
offering of Registrable Securities shall reasonably request, and do any and all other acts and things which may be reasonably necessary or advisable to enable each such Holder and underwriter to consummate the disposition in each such jurisdiction
of such Registrable Securities owned by such Holder; provided, however, that the Company shall not be required to (i) qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise
be required to qualify but for this Section 3(d), or (ii) take any action which would subject it to general service of process or taxation in any such jurisdiction where it is not then so subject; 
 (e) notify promptly each Holder of Registrable Securities under a Shelf Registration Statement that has provided the information required by
Section 2.1(d) and, if requested by such Holder, confirm such advice in writing promptly (i) when a Shelf Registration Statement has become effective and when any post-effective amendments thereto have become effective, (ii) of any
request by the SEC or any state securities authority for post-effective amendments and supplements to a Shelf Registration Statement and Prospectus or for additional information relating thereto after the Shelf Registration Statement has become
effective, (iii) of the issuance by the SEC or any state securities authority of any stop order suspending the effectiveness of a Shelf Registration Statement or the initiation of any proceedings for that purpose, (iv) of the happening of
any event or the discovery of any facts during the period a Shelf Registration Statement is effective which makes any statement made in such Shelf Registration Statement or the related Prospectus untrue in any material respect or which requires the
making of any changes in such Shelf Registration Statement or Prospectus in order to make the statements therein (in the case of the Prospectus in light of the circumstances under which they were made) not misleading, (v) of the receipt by the
Company of any notification with respect to the suspension of the qualification of the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose and (vi) of any determination by the
Company that a post-effective amendment to such Shelf Registration Statement would be appropriate, other than a post-effective amendment solely to add selling Holders; 
 (f) furnish to Holders’ Counsel on behalf of the Holders of Registrable Securities (i) copies of any comment letters received from the SEC with respect to a Shelf Registration Statement, and, if requested,
with respect to any documents incorporated therein by reference and (ii) any other request by the SEC or any state securities authority for amendments or supplements to a Shelf Registration Statement and Prospectus or for additional information
with respect to the Shelf Registration Statement and Prospectus; 
 (g) use reasonable best efforts to obtain the withdrawal of any order
suspending the effectiveness of a Shelf Registration Statement at the earliest possible moment and provide prompt notice to each Holder of the withdrawal of such order; 
  

 10 

 (h) furnish, upon request, to each Holder of Registrable Securities that has provided the information
required by Section 2.1(d), and each underwriter, if any, without charge, at least one conformed copy of each Shelf Registration Statement and any post-effective amendment thereto, including financial statements and schedules (without documents
incorporated therein by reference and all exhibits thereto, unless requested); 
 (i) if electronic global certificates for the Registrable
Securities are not then available, cooperate with the selling Holders of Registrable Securities to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends
(other than as required by applicable law); and enable such Registrable Securities to be in such denominations (consistent with the provisions of the Indenture) and registered in such names as the selling Holders or the underwriters, if any, may
reasonably request at least three business days prior to the closing of any sale of Registrable Securities; 
 (j) upon the occurrence of
any event or the discovery of any facts, each as contemplated by Sections 3(e)(ii), (iii), (iv), (v) and (vi) hereof, as promptly as practicable after the occurrence of such an event, use reasonable best efforts to prepare a post-effective
amendment to the Shelf Registration Statement or amendment or supplement to the related Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter delivered to the purchasers of the
Registrable Securities, such Prospectus will not contain at the time of such delivery any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading or will remain so qualified. At such time as such public disclosure is otherwise made or the Company determines that such disclosure is not necessary, in each case to correct any misstatement of a material fact or to
include any omitted material fact, the Company agrees promptly to notify each Holder of Registrable Securities covered by such Shelf Registration Statement of such determination and to furnish each Holder such number of copies of the Prospectus as
amended or supplemented, as such Holder may reasonably request; 
 (k) no less than three business days after the filing of any Shelf
Registration Statement, any Prospectus, any amendment to a Shelf Registration Statement or amendment or supplement to a Prospectus (other than amendments and supplements that do nothing more than name Holders and provide information with respect
thereto), provide copies of such document to the Trustee on behalf of such Holders, and make representatives of the Company, as shall be reasonably requested by the Holders’ Counsel, available for discussion of such document; 
 (l) obtain CUSIP numbers for all Registrable Securities not later than the effective date of the Shelf Registration Statement and provide the Trustee
with printed certificates for the Registrable Securities in a form eligible for deposit with the Depositary; 
 (m)(i) cause the Indentures
to be qualified under the 1939 Act in connection with the registration of the Registrable Securities, (ii) cooperate with the Trustee and the Holders to effect such changes to the Indentures as may be required for the Indentures to be so
qualified in accordance with the terms of the 1939 Act, and (iii) execute, and use reasonable 

  

 11 

 
best efforts to cause the Trustee to execute, all documents as may be required to effect such changes, and all other forms and documents required to be filed
with the SEC to enable the Indentures to be so qualified in a timely manner; 
 (n) subject to the last paragraph of this Section 3(n),
enter into such customary agreements (including, if requested, an underwriting agreement in customary form) and take all other customary and appropriate actions, if any, as the Majority Holders shall reasonably request in writing in order to
expedite or facilitate the disposition of such Registrable Securities, including, but not limited to: 
 (i) obtain opinions
of counsel to the Company and updates thereof addressed to each selling Holder and the underwriters, if any, covering the matters set forth in the opinions of such counsel delivered at the Closing Date as are customarily covered in legal opinions in
connection with underwritten offering of securities; 
 (ii) obtain “comfort” letters and updates thereof from the
Company’s independent certified public accountants (and, if necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired by the Company for which financial statements are, or are
required to be, included in the Shelf Registration Statement) addressed to the board of directors of the Company and the underwriters, if any, and use reasonable efforts to have such letter addressed to the selling Holders of Registrable Securities
(to the extent consistent with Statement on Auditing Standards No. 72 of the American Institute of Certified Public Accounts), such letters containing statements and information of the type ordinarily included in accountant’s “comfort
letters”; 
 (iii) if an underwriting agreement is entered into, cause the same to set forth indemnification provisions
and procedures substantially equivalent to the indemnification provisions and procedures set forth in Section 4 hereof with respect to the underwriters and all other parties to be indemnified pursuant to said Section or, at the request of any
underwriters, in the form customarily provided to such underwriters in similar types of transactions; and 
 (iv) deliver
such documents and certificates as may be reasonably requested and as are customarily delivered in similar offerings to the Holders of a majority in principal amount of the Registrable Securities being sold and the managing underwriters, if any.

 The above shall be done only in connection with any underwritten offering of not less than one half of the Registrable Securities using such Shelf
Registration Statement pursuant to an underwriting or similar agreement as and to the extent required thereunder, and as reasonably requested by the Majority Holders thereto. Anything herein to the contrary notwithstanding, the Company will not be
required to pay the costs and expenses of, or to participate in the marketing or “road show” presentations of, more than one underwritten offering of Registrable Securities every 12 months commencing on the effective date of the Shelf
Registration Statement. The Company will not be required to pay the costs and expenses of, or to participate in the marketing 
  

 12 

 or “road show” presentations of, an underwritten offering of Registrable Securities unless requested by the
Majority Holders; 
 (o) if reasonably requested in connection with a disposition of Registrable Securities, make available for inspection
during business hours by representatives of the Holders of the Registrable Securities, any underwriters participating in any disposition pursuant to a Shelf Registration Statement and any counsel or accountant retained by any of the foregoing, all
appropriate financial and other records, pertinent corporate documents and properties of the Company reasonably requested in writing by any such persons, and cause the respective officers, directors, employees, and any other agents of the Company to
supply all information reasonably requested by any such representative, underwriter, counsel or accountant in connection with a Shelf Registration Statement, and make such representatives of the Company available for discussion of such documents as
shall be reasonably requested by the Initial Purchasers, in each case as is customary for “due diligence” investigations; provided that, to the extent the Company, in its reasonable discretion, agrees to disclose material non-public
information, such persons shall first agree in writing with the Company that any such non-public information shall be kept confidential by such persons and shall be used solely for the purposes of exercising rights under this Agreement and such
person shall not engage in trading any securities of the Company until such material non-public information becomes properly publicly available, unless (i) disclosure of such information is required by court or administrative order or is
necessary to respond to inquiries of regulatory authorities, (ii) disclosure of such information is required by law (including any disclosure requirements pursuant to federal securities laws in connection with the filing of any Shelf
Registration Statement or the use of any Prospectus referred to in this Agreement upon a customary opinion of counsel for such persons delivered and reasonably satisfactory to the Company), (iii) such information becomes generally available to
the public other than as a result of a disclosure or failure to safeguard by any such person, (iv) such information becomes available to any such person from a source other than the Company and such source is not bound by a confidentiality
agreement, or (v) such non-public information ceases to be material; provided further, that, the foregoing inspection and information gathering shall, to the greatest extent possible, be coordinated on behalf of all the Holders and the
other parties entitled thereto by Holders’ Counsel; 
 (p) if requested in writing by any selling Holder of Registrable Securities that
has provided the information required by Section 2.1(d), a reasonable time prior to filing the Shelf Registration Statement, any Prospectus forming a part thereof, any amendment to the Shelf Registration Statement or amendment or supplement to
such Prospectus (other than amendments and supplements that do nothing more than name Holders and provide information with respect thereto), (i) provide copies of such document to the Holders of Registrable Securities that have provided the
information required by Section 2.1(d), to Holders’ Counsel and to the underwriter or underwriters of an underwritten offering of Registrable Securities, if any, (ii) make such changes in any such document prior to the filing thereof
as Holders’ Counsel or the underwriter or underwriters reasonably agree should be included therein and provide to the Company in writing for inclusion therein within three business days of delivery of such copies, (iii) if requested by any
selling Holder of Registrable Securities that has provided the information required by Section 2.1(d), not file any such document in a form (A) to which the Majority Holders, Holders’ Counsel or any underwriter shall not have
previously been advised and furnished a copy of or (B) to which the Majority Holders, Holders’ Counsel or any underwriter 

  

 13 

 
shall reasonably object within three business days of delivery of such copies, and (iv) make the representatives of the Company available for discussion
of such document as shall be reasonably requested in writing by the Holders of Registrable Securities, Holders’ Counsel or any underwriter; provided, however, that the foregoing discussion shall be coordinated on behalf of the
parties entitled thereto by the Holders’ Counsel; 
 (q) if requested by any selling Holder or the underwriters, if any, incorporate in
the Shelf Registration Statement or Prospectus, pursuant to a supplement or post-effective amendment if necessary, such information as such selling Holder or underwriter, if any, may reasonable request in writing to have included therein with
respect to the name or names of such selling Holder, the number of shares of Common Stock or principal amount of Debentures owned by such Holder, the plan of distribution of the Registrable Securities (as required by Item 508 of Regulation
S-K), the principal amount of Debentures or number of shares of Common Stock being sold, the purchase price being paid therefor, and any other terms of the offering of the Registrable Securities to be sold in such offering; 
 (r) use reasonable best efforts to cause all Registrable Securities to be listed on any securities exchange or inter-dealer quotation system on which
similar debt or equity securities issued by the Company are then listed if requested by the Majority Holders, or if requested by the underwriter or underwriters of an underwritten offering of Registrable Securities, if any; 
 (s) use commercially reasonable efforts to cause the Debentures to be rated by the appropriate rating agencies if requested by the underwriter or
underwriters of an underwritten public offering of Debentures, if any; 
 (t) otherwise comply with all applicable rules and regulations of
the SEC and make available to its security holders, as soon as reasonably practicable, an earnings statement covering at least 12 months which shall satisfy the provisions of Section 11(a) of the 1933 Act and Rule 158 thereunder; and

 (u) cooperate and assist in any filings required to be made with the FINRA and in the performance of any due diligence investigation by
any underwriter and its counsel (including any “qualified independent underwriter” that is required to be retained in accordance with the rules and regulations of FINRA). 
 Without limiting the provisions of Section 2.1(d), the Company may (as a condition to such Holder’s participation in the Shelf Registration)
require each Holder of Registrable Securities to furnish to the Company such information regarding the Holder and the proposed distribution by such Holder of such Registrable Securities as the Company may from time to time reasonably request in
writing. 
 Each Holder agrees that, upon receipt of any notice from the Company of the happening of any event or the discovery of any facts,
each of the kind described in Section 3(e)(ii), (iii), (iv), (v) or (vi) hereof, such Holder will forthwith discontinue disposition of Registrable Securities pursuant to the Prospectus included in the Shelf Registration Statement
until such Holder’s receipt of the copies of the supplemented or amended Prospectus 

  

 14 

 
contemplated by Section 3(j) hereof or written notice from the Company that the Shelf Registration Statement is again effective and no amendment or
supplement is needed, and, if so directed by the Company, such Holder will deliver to the Company (at its expense) all copies in such Holder’s possession, other than permanent file copies then in such Holder’s possession, of the Prospectus
covering such Registrable Securities current at the time of receipt of such notice. 
 If any of the Registrable Securities covered by any
Shelf Registration Statement are to be sold in an underwritten offering, the underwriter or underwriters and manager or managers that will manage such offering will be selected by the Majority Holders of such Registrable Securities included in such
offering and shall be acceptable to the Company. No Holder of Registrable Securities may participate in any underwritten offering hereunder unless such Holder (a) agrees to sell such Holder’s Registrable Securities on the basis provided in
any underwriting arrangements approved by the persons entitled hereunder to approve such arrangements and (b) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents required under
the terms of such underwriting arrangements. 
 4. Indemnification; Contribution. 
 (a) The Company agrees to indemnify and hold harmless each Initial Purchaser, each Holder, each Person who participates as an underwriter, if any (any
such Person being an “Underwriter”) and each Person, if any, who controls any such Holder or Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act as follows: 
 (i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or
alleged untrue statement of a material fact contained in any Shelf Registration Statement (or any amendment or supplement thereto) pursuant to which Registrable Securities were registered under the 1933 Act, including all documents incorporated
therein by reference, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a
material fact contained in any Prospectus (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus (or any amendment or supplement thereto) or the omission or alleged omission therefrom of a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading; 
 (ii) against
any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or
threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to Section 4(d) below) any such settlement is effected with the written
consent of the Company; and 
 (iii) against any and all expense whatsoever, as incurred (including the reasonable and
documented fees and disbursements of counsel chosen by 

  

 15 

 
any indemnified party), reasonably incurred and documented in investigating, preparing or defending against any litigation, or any investigation or
proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under
subparagraph (i) or (ii) above; 
 provided, however, that this indemnity agreement shall not apply to any loss, liability, claim,
damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Initial
Purchaser, any Holder or Underwriter, if any, expressly for use in a Shelf Registration Statement (or any amendment thereto), any Prospectus (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus (or any amendment or
supplement thereto) or the gross negligence, willful misconduct or bad faith of any such party seeking indemnification. 
 (b) Each Holder,
severally, but not jointly, agrees to indemnify and hold harmless the Company, each Initial Purchaser, each Underwriter, if any, and the other selling Holders, and each of their respective directors and officers, and each Person, if any, who
controls the Company, each Initial Purchaser, any Underwriter or any other selling Holder within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, against any and all loss, liability, claim, damage and expense
described in the indemnity contained in Section 4(a) hereof, as incurred and documented, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Shelf Registration Statement (or any
amendment thereto) or any Prospectus included therein (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with written information with respect to
such Holder furnished to the Company by or on behalf of such Holder expressly for use in the Shelf Registration Statement (or any amendment thereto) or such Prospectus (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus
(or any amendment or supplement thereto); provided, however, that no such Holder shall be liable for any claims hereunder in excess of the amount of net proceeds received by such Holder from the sale of Registrable Securities pursuant
to such Shelf Registration Statement. 
 (c) Each indemnified party shall give notice as promptly as reasonably practicable to each
indemnifying party of any action or proceeding commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the
extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. In case any such action, claim, suit, investigation or
proceeding shall be brought against any indemnified party and it shall notify the Company of the commencement thereof, the Company shall be entitled to participate therein and to assume the defense thereof; provided, however, that in
the event that any such action, claim, suit, investigation or proceeding includes both an indemnified party and the Company, and such indemnified party reasonably concludes that there may be legal defenses available to it or other indemnified
parties that are different from or in addition to those available to the Company, or if the Company fails to assume the defense of the action, claim, suit, 

  

 16 

 
investigation or proceeding within 30 days of being notified of the commencement of any such action, claim, suit, investigation or proceeding, then such
indemnified party may employ separate counsel to represent or defend it in any such action, claim, suit, investigation or proceeding and the Company will pay the reasonable fees and disbursements of such counsel; provided, further, that the Company
will not be required to pay the fees and disbursements of more than one counsel for all indemnified parties (and one separate local counsel). In any action, claim, suit, investigation or proceeding the defense of which the Company assumes, the
indemnified party will have the right to participate in such litigation and to retain its own counsel at such indemnified party’s own expense. No indemnifying party shall (i) without the prior written consent of the indemnified parties
(which consent shall not be unreasonably withheld), settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any
claim whatsoever in respect of which indemnification or contribution could be sought under this Section 4 (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent
(A) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (B) does not include a statement as to or an admission of fault, culpability or a
failure to act by or on behalf of any indemnified party or (ii) be liable for any settlement of any such action effected without its prior written consent (which consent shall not be unreasonably withheld). 
 (d) Notwithstanding clause (ii) of Section 4(c), if at any time an indemnified party shall have requested an indemnifying party to reimburse
the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 4(a)(ii) effected without its written consent if (i) such settlement is
entered into more than 60 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered
into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement. 
 (e) If the indemnification provided for in this Section 4 is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses
referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, in such proportion as is appropriate to reflect the
relative fault of the Company on the one hand and the Holders, the Initial Purchasers and Underwriters on the other hand in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as well
as any other relevant equitable considerations. 
 The relative fault of the Company on the one hand and the Holders, Initial Purchasers and
Underwriters on the other hand shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied
by the Company, or by the Holders, Initial Purchasers and Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
  

 17 

 The Company, the Holders, the Initial Purchasers and Underwriters, if any, agree that it would not be
just and equitable if contribution pursuant to this Section 4 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 4. The
aggregate amount of losses, liabilities, claims, damages and expenses incurred and documented by an indemnified party and referred to above in this Section 4 shall be deemed to include any legal or other expenses reasonably incurred by such
indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue
statement or omission or alleged omission. 
 Notwithstanding the provisions of this Section 4, no Initial Purchaser shall be required
to contribute any amount in excess of the discount or commission payable to such Initial Purchaser with respect to securities underwritten by it and distributed to the public. 
 No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any
Person who was not guilty of such fraudulent misrepresentation. 
 For purposes of this Section 4, each Person, if any, who controls an
Initial Purchaser, Holder or Underwriter, if any, within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as such Initial Purchaser, Holder or Underwriter, if any, and each
director and officer of the Company, and each Person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Company. The
obligations of the Company, the Initial Purchasers and the Holders pursuant to this Section 4 shall be in addition to any liability that such party may otherwise have. The Initial Purchasers’ respective obligations to contribute pursuant
to this Section 4 are several in proportion to the principal amount of Debentures set forth opposite their respective names in Schedule A of the Purchase Agreement and not joint. 
 5. Miscellaneous. 
 5.1 Rule 144
and Rule 144A. During the Effectiveness Period, for so long as the Company is subject to the reporting requirements of Section 13 or 15(d) of the 1934 Act, the Company covenants that it will file the reports required to be filed by it under
Section 13 or 15(d) of the 1934 Act and the rules and regulations adopted by the SEC thereunder. If during the Effectiveness Period the Company ceases to be so required to file such reports, the Company covenants that it will upon the request
of any Holder of Registrable Securities (a) make publicly available such information as is necessary to permit sales pursuant to Rule 144 under the 1933 Act, (b) deliver such information to a prospective purchaser as is necessary to permit
sales pursuant to Rule 144A under the 1933 Act and it will take such further action as any Holder of Registrable Securities may reasonably request for such purpose, and (c) take such further action that is reasonable in the circumstances, in
each case, to the extent required from time to time to enable such Holder to sell its Registrable Securities without registration under the 1933 Act within the limitation of the exemptions provided by (i) Rule 144 under the 1933 Act, as such
rule may be amended from time to time, (ii) Rule 144A under the 1933 Act, as such rule may be 

  

 18 

 
amended from time to time, or (iii) any similar rules or regulations hereafter adopted by the SEC. During the Effectiveness Period, upon the request of
any Holder of Registrable Securities, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements. 
 5.2 No Inconsistent Agreements. The Company has not entered into and the Company shall not, after the date of this Agreement, enter into any agreement which is inconsistent in any material respect with the
rights granted to the Holders of Registrable Securities in this Agreement or otherwise conflicts with the provisions hereof. The rights granted to the Holders hereunder do not and will not for the term of this Agreement in any way conflict with the
rights granted to the holders of any of the Company’s other issued and outstanding securities under any such agreements. 
 5.3 No
Adverse Actions Affecting Registration Rights. Subject to the rights of the Company to invoke and maintain a Suspension Period, the Company shall not, directly or indirectly, intentionally take any action with respect to the Registrable
Securities as a class that would adversely affect the ability of the Holders of Registrable Securities to include such Registrable Securities in a registration undertaken pursuant to this Agreement. 
 5.4 Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or
supplemented, and waivers or consents to departures from the provisions hereof may not be given unless the Company has obtained the written consent of the Majority Holders affected by such amendment, modification, supplement, waiver or departure.
Notwithstanding the foregoing, this Agreement may be amended by a written agreement among the Company and the Initial Purchasers, without the consent of the Holders of the Registrable Securities, in order to cure any ambiguity or to correct or
supplement any provision contained herein, provided that no such amendment shall adversely affect the interest of the Holders of Registrable Securities. Each Holder of Registrable Securities outstanding at the time of any amendment, modification,
waiver or consent pursuant to this Section 5.4, shall be bound by such amendment, modification, waiver or consent, whether or not any notice or writing indicating such amendment, modification, waiver or consent is delivered to such Holder.

 5.5 Notices. All notices (other than notices specified herein to be given by the Company by press release) and other communications
provided for or permitted hereunder shall be made in writing by hand delivery, registered first-class mail, facsimile, or any courier guaranteeing overnight delivery (a) if to a Holder, at the most current address given by such Holder to the
Company in a Questionnaire or by means of a notice given in accordance with the provisions of this Section 5.5, which address initially is the address set forth in the Purchase Agreement with respect to the Initial Purchasers; and (b) if
to the Company, initially at the Company’s address set forth in the Purchase Agreement, and thereafter at such other address of which notice is given in accordance with the provisions of this Section 5.5. 
 All such notices and communications shall be deemed to have been duly given: on the date of any notice by press release; at the time delivered by hand,
if personally delivered; two business days after being deposited in the mail, postage prepaid, if mailed; when receipt is 
  

 19 

 acknowledged, if sent by facsimile; and on the next business day if timely delivered to an overnight courier. 

Copies of all such notices, demands, or other communications shall be concurrently delivered by the person giving the same to the Trustee under the
Indentures, at the address specified in such Indentures. 
 5.6 Successors and Assigns. This Agreement shall inure to the benefit of
and be binding upon the successors, assigns and transferees of each of the parties, including, without limitation and without the need for an express assignment, subsequent Holders; provided that nothing herein shall be deemed to permit any
assignment, transfer or other disposition of Registrable Securities in violation of the terms of the Purchase Agreement or the Indentures. If any transferee of any Holder shall acquire Registrable Securities, in any manner, whether by operation of
law or otherwise, such Registrable Securities shall be held subject to all of the terms of this Agreement, and by taking and holding such Registrable Securities such person shall be conclusively deemed to have agreed to be bound by and to perform
all of the terms and provisions of this Agreement, including the restrictions on resale set forth in this Agreement and, if applicable, the Purchase Agreement, and such person shall be entitled to receive the benefits hereof. 
 5.7 Third Party Beneficiaries. The Initial Purchasers (even if the Initial Purchasers are not Holders of Registrable Securities) shall be a third
party beneficiaries to the agreements made hereunder between the Company, on the one hand, and the Holders, on the other hand, and shall have the right to enforce such agreements directly to the extent they deem such enforcement necessary or
advisable to protect their rights or the rights of Holders hereunder. Each Holder of Registrable Securities shall be a third party beneficiary to the agreements made hereunder between the Company, on the one hand, and the Initial Purchasers, on the
other hand, and shall have the right to enforce such agreements directly to the extent it deems such enforcement necessary or advisable to protect its rights hereunder. 
 5.8 Specific Enforcement. Without limiting the remedies available to Initial Purchasers and the Holders, the Company acknowledges that any failure by the Company to comply with its obligations under
Section 2.1 hereof may result in material irreparable injury to the Initial Purchasers or the Holders for which there is no adequate remedy at law, that it may not be possible to measure damages for such injuries precisely and that, in the
event of any such failure, any Initial Purchaser or any Holder may seek such relief as may be required to specifically enforce the Company’s obligations under Section 2.1 hereof. 
 5.9 Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 
 5.10
Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. 
  

 20 

 5.11 GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICT OF LAWS THEREOF. 
 5.12 Severability. In the event
that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the
remaining provisions contained herein shall not be affected or impaired thereby. 
 5.13 Entire Agreement. This Agreement is intended
by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. There are no restrictions,
promises, warranties or undertakings, other than those set forth or referred to herein with respect to the registration rights granted by the Company with respect to the Registrable Securities. This Agreement supersedes all prior agreements and
understandings between the parties with respect to such subject matter. 
  

 21 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	LINCARE HOLDINGS INC.
		
	By	 	 /s/ Paul G. Gabos

	Name:	 	Paul G. Gabos
	Title:	 	Chief Financial Officer

 Registration Rights Agreement 
 Signature Page 

			
	Confirmed and accepted as of the date first above written:
	
	 MERRILL LYNCH & CO.
 MERRILL
LYNCH, PIERCE, FENNER & SMITH INCORPORATED

		
	By:	 	 /s/ James P. Boylan

		 	Authorized Signatory
	
	DEUTSCHE BANK SECURITIES INC.
		
	By:	 	 /s/ Bill Stitt

		 	Authorized Signatory
		
	By:	 	 /s/ Ananth Bhogaraju

		 	Authorized Signatory

 For themselves and as Representatives of the other Initial Purchasers named in Schedule A to the
Purchase Agreement. 
 Registration Rights Agreement 
 Signature PageFirst Amendment to Credit Agreement dated as of October 31, 2007

 Exhibit 4.4 
 EXECUTION VERSION 
 FIRST AMENDMENT TO CREDIT AGREEMENT 
 This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of October 19, 2007, is by and among LINCARE
HOLDINGS INC., a Delaware corporation (the “Borrower”), each of the Borrower’s Subsidiaries (individually a “Guarantor” and collectively the “Guarantors”; together with the Borrower,
individually a “Credit Party”, and collectively the “Credit Parties”), the Required Lenders signatory hereto and BANK OF AMERICA, N. A., as Agent for the Lenders (in such capacity, the
“Agent”). 
 WITNESSETH 
 WHEREAS, the Credit Parties, the Lenders and the Agent have entered into that certain Credit Agreement dated as of December 1, 2006 as amended, restated, supplemented, or otherwise modified from time
to time (the “Existing Credit Agreement”); 
 WHEREAS, the Borrower has requested, and the Lenders have agreed, to
amend certain provisions of the Existing Credit Agreement as set forth hereinbelow. 
 NOW, THEREFORE, in consideration of the
agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 
 PART I 
 DEFINITIONS 
 SUBPART 1.1 Certain Definitions. Unless otherwise defined herein or the context otherwise requires, the following terms used in this
Amendment, including its preamble and recitals, have the following meanings: 
 “Amended Credit Agreement”
means the Existing Credit Agreement as amended hereby. 
 SUBPART 1.2 Other Definitions. Unless otherwise defined herein or the
context otherwise requires, terms used in this Amendment, including its preamble and recitals, have the meanings provided in the Existing Credit Agreement. 

 PART II 
 AMENDMENTS TO EXISTING CREDIT AGREEMENT 
 Effective on the date hereof, the Existing Credit Agreement
is hereby amended in accordance with this Part II. 
 SUBPART 2.1 Amendments to Section 1.1. Section 1.1 of
the Existing Credit Agreement is hereby amended in the following respects: 
 (a) The definition of “Convertible Notes” is
hereby amended and restated in its entirety to read as follows: 
 “Convertible Notes” means the 2003
Convertible Notes and the 2007 Convertible Notes. 
 (b) The definition of “Convertible Note Indenture” is hereby amended
and restated in its entirety to read as follows: 
 “Convertible Note Indenture” means the 2003 Convertible
Note Indenture, the 2007 Series A Convertible Note Indenture and the 2007 Series B Convertible Note Indenture. 
 (c) The definition of
“Net Cash Proceeds” is hereby amended and restated in its entirety to read as follows: 
 “Net Cash
Proceeds” means the aggregate cash proceeds (including cash actually received by way of deferred payment pursuant to a promissory note, receivable, or otherwise) received by a Consolidated Party from any Equity Issuance or Convertible Note
Issuance, net of (a) direct costs (including, without limitation, legal, accounting and investment banking fees and sales commissions) and (b) taxes paid or payable as a result thereof; it being understood that “Net Cash
Proceeds” shall include, without limitation, any cash received upon the sale or other disposition of any non-cash consideration received by any Consolidated Party in any Equity Issuance or Convertible Note Issuance. 
 (d) The definition of “Restricted Payment” is hereby amended and restated in its entirety to read as follows: 
 “Restricted Payment” means (i) any dividend or other distribution, direct or indirect, on account of any shares of
any class of Capital Stock of any Consolidated Party, now or hereafter outstanding, (ii) any redemption, retirement, sinking fund or similar payment, purchase or other acquisition for value, direct or indirect, of any shares of any class of
Capital Stock of any Consolidated Party, now or hereafter outstanding, and (iii) any payment made to retire, or to obtain the surrender of, any outstanding warrants, options or other rights to acquire shares of any class of Capital Stock of any
Consolidated Party, now or hereafter outstanding (it being understood that the term “Restricted 

  

 2 

 
Payment” shall not include (x) the repayment or redemption of the Convertible Notes at any time prior to the conversion of such Convertible Notes
to Capital Stock of the Borrower or (y) any payment made in connection with the conversion of the Convertible Notes). 
 (e) The
following new definitions are hereby added to the Existing Credit Agreement in the appropriate alphabetical order to read as follows: 
 “2003 Convertible Note Indenture” means that certain Convertible Note Indenture dated as of June 11, 2003 by and between the Borrower and U.S. Bank Trust National Association, as Trustee.

 “2003 Convertible Notes” means the Borrower’s 3.00% Convertible Senior Debentures due June 15,
2033 (each as amended, modified, extended, renewed or restated from time to time). 
 “2007 Convertible
Notes” means the 2007 Series A Convertible Notes and the 2007 Series B Convertible Notes. 
 “2007 Series A
Convertible Note Indenture” means that certain Convertible Senior Note Indenture to be entered into by and between the Borrower and U.S. Bank Trust National Association, as Trustee with respect to the 2007 Series A Convertible Notes.

 “2007 Series A Convertible Notes” means the Borrower’s Series A Convertible Senior Debentures due
2037 (each as amended, modified, extended, renewed or restated from time to time) to be issued under the 2007 Series A Convertible Note Indenture. 
 “2007 Series B Convertible Note Indenture” means that certain Convertible Senior Note Indenture to be entered into by and between the Borrower and U.S. Bank Trust National Association, as Trustee with
respect to the 2007 Series B Convertible Notes. 
 “2007 Series B Convertible Notes” means the
Borrower’s Series B Convertible Senior Debentures due 2037 (each as amended, modified, extended, renewed or restated from time to time) to be issued under the 2007 Series B Convertible Note Indenture. 
 “Convertible Note Issuance” means the issuance by the Borrower of the 2007 Series A Convertible Notes and the 2007 Series
B Convertible Notes. 
 “First Amendment Effective Date” shall be the date on which the 2007 Convertible
Notes executed by the Borrower are authenticated by the applicable trustee. 
 SUBPART 2.2 Amendments to Section 8.1(c).

 (a) The word “and” at the end of Section 8.1(j) is hereby deleted. 
  

 3 

 (b) Section 8.1(k) of the Existing Credit Agreement is hereby amended and restated in its entirety
to read as follows: 
 (k) Indebtedness of the Borrower arising under the 2003 Convertible Note Indenture and the 2003
Convertible Notes in an aggregate principal amount of up to $275,000,000 (and renewals, refinancings and extensions thereof on terms and conditions no less favorable to the Borrower than the terms and conditions of the 2003 Convertible Note
Indenture); 
 (c) A new Section 8.1(l) is hereby added to the Existing Credit Agreement to read as follows: 
 (l) Indebtedness of the Borrower arising under the 2007 Series A Convertible Note Indenture and the 2007 Series A Convertible Notes in an
aggregate principal amount of up to $275,000,000 (and renewals, refinancings and extensions thereof on terms and conditions no less favorable to the Borrower than the terms and conditions of the 2007 Series A Convertible Note Indenture and the 2007
Series A Convertible Notes as in effect on the First Amendment Effective Date); and 
 (d) A new Section 8.1(m) is hereby added to the
Existing Credit Agreement to read as follows: 
 (m) Indebtedness of the Borrower arising under the 2007 Series B Convertible
Note Indenture and the 2007 Series B Convertible Notes in an aggregate principal amount of up to $275,000,000 (and renewals, refinancings and extensions thereof on terms and conditions no less favorable to the Borrower than the terms and conditions
of the 2007 Series B Convertible Note Indenture and the 2007 Series B Convertible Notes as in effect on the First Amendment Effective Date). 
 SUBPART 2.3 Amendments to Section 8.7. Section 8.7 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
  

	 	8.7	Restricted Payments. 

 The
Credit Parties will not permit any Consolidated Party to, directly or indirectly, declare, order, make or set apart any sum for or pay any Restricted Payment, except, so long as no Default or Event of Default shall have occurred or would occur as a
result thereof, (a) to make dividends payable solely in the same class of Capital Stock of such Person, (b) to make dividends or other distributions payable to any Credit Party (directly or indirectly through Subsidiaries) and (c) any
other additional Restricted Payment, provided that with respect to any Restricted Payment under this clause (c) if as of the end of the most recently tested fiscal quarter or after giving pro forma effect to any such Restricted Payment the
Leverage Ratio is greater than or equal to 1.50 to 1.0, the aggregate amount of all such Restricted Payments made pursuant to this clause (c) shall not exceed (A) during the period beginning on the First Amendment Effective Date and

  

 4 

 
ending on June 1, 2008, an amount equal to the Net Cash Proceeds received by the Borrower from the Convertible Note Issuance and (B) during the
period following June 1, 2008, the greater of (x) $500,000,000 and (y) the amount of Restricted Payments made since the First Amendment Effective Date up to such date, excluding in the case of (x) and (y) any Restricted
Payments made pursuant to subsection (A) immediately above with the Net Cash Proceeds received by the Borrower from the Convertible Note Issuance. 
 PART III 
 CONDITIONS TO EFFECTIVENESS 
 SUBPART 3.1 Effectiveness of First Amendment. If all of the conditions set forth in this Part III shall have been satisfied, this Amendment
shall automatically be and become effective simultaneously with the closing of the offering by the Borrower of the 2007 Convertible Notes. The closing of the offering by the Borrower of the 2007 Convertible Notes shall be deemed for purposes of this
Amendment to occur upon the execution by the Borrower of the 2007 Convertible Notes and the authentication of the 2007 Convertible Notes by the applicable trustee. Following the First Amendment Effective Date (as defined in the Amended Credit
Agreement) this Amendment shall be known, and may be referred to, as “Amendment No. 1.” 
 SUBPART 3.2
Execution of Counterparts of Amendment. The Agent shall have received counterparts of this Amendment, which collectively shall have been duly executed on behalf of each of the Borrower, the Guarantors and the Required Lenders. 

SUBPART 3.3 Other Items. The Agent shall have received such other documents, agreements or information which may be reasonably requested
by the Agent. 
 PART IV 
 MISCELLANEOUS 
 SUBPART 4.1 Representations and Warranties. The Borrower hereby represents and warrants to the
Agent and the Lenders that, after giving effect to this Amendment, (a) no Default or Event of Default exists and (b) the representations and warranties set forth in Section 6 of the Existing Credit Agreement and in the other Credit
Documents are, subject to the limitations set forth therein, true and correct in all material respects as of the date hereof (except for those which expressly relate to an earlier date). 
 SUBPART 4.2 Reaffirmation of Credit Party Obligations. Each Credit Party hereby ratifies the Credit Agreement and the other Credit
Documents and acknowledges and reaffirms (a) that it is bound by all terms of the Credit Agreement and the other Credit Documents applicable to it and (b) that it is responsible for the observance and full performance of its respective
Credit Party Obligations. 
 SUBPART 4.3 Cross-References. References in this Amendment to any Part or Subpart are, unless
otherwise specified, to such Part or Subpart of this Amendment. 
  

 5 

 SUBPART 4.4 Instrument Pursuant to Existing Credit Agreement. This Amendment is a Credit
Document executed pursuant to the Existing Credit Agreement and shall (unless otherwise expressly indicated therein) be construed, administered and applied in accordance with the terms and provisions of the Existing Credit Agreement. 
 SUBPART 4.5 References in Other Credit Documents. At such time as this Amendment shall become effective pursuant to the terms of
Subpart 3.1, all references in the Credit Documents to the “Credit Agreement” shall be deemed to refer to the Amended Credit Agreement. 
 SUBPART 4.6 Counterparts/Telecopy. This Amendment may be executed by the parties hereto in several counterparts, each of which shall be deemed to be an original and all of which shall constitute together
but one and the same agreement. Delivery of executed counterparts of this Amendment by telecopy or other electronic means shall be effective as an original and shall constitute a representation that an original shall be delivered. 
 SUBPART 4.7 Governing Law. THIS AMENDMENT SHALL BE DEEMED TO BE A CONTRACT MADE UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW
YORK. 
 SUBPART 4.8 Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the parties
hereto and their respective successors and assigns. 
 SUBPART 4.9 General. Except as amended hereby, the Existing Credit
Agreement and all other Credit Documents shall continue in full force and effect. 
 SUBPART 4.10 Sunset. Notwithstanding any
provision set forth herein, if the closing of the offering by the Borrower of the 2007 Convertible Notes does not occur on or prior to December 31, 2007, this Amendment shall terminate without effect. 
  

 6 

 IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this Amendment to be
duly executed and delivered as of the date first above written. 
  

							
	BORROWER:	 	LINCARE HOLDINGS INC.,
		 	a Delaware corporation
			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer
		
	GUARANTORS:	 	LINCARE INC.,
		 	a Delaware corporation
			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer
		
		 	LINCARE PROCUREMENT INC.,
		 	a Delaware corporation
			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer
		
		 	LINCARE ASSET MANAGEMENT LP,
		 	a Nevada limited partnership
			
		 		 	By: Lincare Holdings Inc., a
		 		 	Delaware corporation, its general partner
				
		 		 	By:	 	 /s/ Paul G. Gabos

		 		 	Name:	 	Paul G. Gabos
		 		 	Title:	 	Chief Financial Officer
		
		 	LINCARE OF NEW YORK INC.,
		 	a New York corporation
			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer

					
		 	LINCARE PHARMACY SERVICES INC.,
		 	a Delaware corporation
			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer
		
		 	 LINCARE LICENSING INC.,
 a Delaware
corporation

			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer
		
		 	 CONVACARE SERVICES INC.,
 an Indiana
corporation

			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer
		
		 	 MED 4 HOME INC.,
 a Delaware
corporation

			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer
		
		 	 ALPHA RESPIRATORY, INC.,
 a Delaware
corporation

			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer
		
		 	 HEALTH CARE SOLUTIONS AT HOME INC.,
 a
Delaware corporation

			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer

					
		 	HOME-CARE EQUIPMENT NETWORK INC.,
		 	a Delaware corporation
			
		 	By:	 	 /s/ Paul G. Gabos

		 	Name:	 	Paul G. Gabos
		 	Title:	 	Chief Financial Officer

					
	AGENT:	 	BANK OF AMERICA, N.A.,
		 	as Agent
			
		 	By:	 	 /s/ Kevin Ahart

		 	Name:	 	Kevin Ahart
		 	Title:	 	Vice President

					
	LENDERS:	 	BANK OF AMERICA, N.A.,
		 	as a Lender
			
		 	By:	 	 /s/ Craig Murlless

		 	Name:	 	Craig Murlless
		 	Title:	 	Senior Vice President

					
		 	Bank of New York,
		 	as a Lender
			
		 	By:	 	 /s/ Mary E. Pohl

		 	Name:	 	Mary E. Pohl
		 	Title:	 	Vice President

  

					
		 	The Bank of Nova Scotia,
		 	as a Lender
			
		 	By:	 	 /s/ James Forward

		 	Name:	 	James Forward
		 	Title:	 	Managing Director

  

					
		 	CALYON NEW YORK BRANCH,
		 	as a Lender
			
		 	By:	 	 /s/ Thomas Randolph

		 	Name:	 	Thomas Randolph
		 	Title:	 	Managing Director
			
		 	By:	 	 /s/ Priya Vrat

		 	Name:	 	Priya Vrat
		 	Title:	 	Director

					
		 	Citibank N.A.,
		 	as a Lender
			
		 	By:	 	 /s/ Brinda Ganguly

		 	Name:	 	Brinda Ganguly
		 	Title:	 	Vice President

  

					
		 	E.Sun Commercial Bank, Ltd., Los Angeles Branch,
		 	as a Lender
			
		 	By:	 	 /s/ Benjamin Lin

		 	Name:	 	Benjamin Lin
		 	Title:	 	E.V.P. & General Manager

  

					
		 	National City Bank,
		 	as a Lender
			
		 	By:	 	 /s/ Deroy Scott

		 	Name:	 	Deroy Scott
		 	Title:	 	Senior Vice President

  

					
		 	PNC Bank, N.A.,
		 	as a Lender
			
		 	By:	 	 /s/ Karin B. Takiff

		 	Name:	 	Karin B. Takiff
		 	Title:	 	Senior Vice President

  

					
		 	RBS Citizens, National Association
		 	(formerly known as Citizens Bank of Massachusetts),
		 	as a Lender
			
		 	By:	 	 /s/ Darcy Salinger

		 	Name:	 	Darcy Salinger
		 	Title:	 	Vice President

  

					
		 	U.S. Bank, N.A.,
		 	as a Lender
			
		 	By:	 	 /s/ Thomas A. Heckman

		 	Name:	 	Thomas A. Heckman
		 	Title:	 	Vice President

  

					
		 	WELLS FARGO BANK, N.A.,
		 	as a Lender
			
		 	By:	 	 /s/ Kevin Combs

		 	Name:	 	Kevin Combs
		 	Title:	 	Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}]]